Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment - Cross, Robert W.; Bornholdt, Zachary A.; Prasad, Abhishek N.; Geisbert, Joan B.; Borisevich, Viktoriya; Agans, Krystle N.; Deer, Daniel J.; Melody, Kevin; Fenton, Karla A.; Feldmann, Heinz; Sprecher, Armand; Zeitlin, Larry; et al. (Nature communications, 2020)
Keywords: 631/250/2152/2153/1291; 631/326/590/1867; 631/326/596/2042; 64; Animals; Antibodies; Antibodies, Monoclonal - administration & dosage; Antibodies, Monoclonal - immunology; Antibodies, Monoclonal - therapeutic use; Antibodies, Viral - administration & dosage; Antibodies, Viral - immunology; Antibodies, Viral - therapeutic use; Ebola Vaccines - immunology; Ebola virus; Ebolavirus; Glycoproteins; Hemorrhagic Fever, Ebola - immunology; Hemorrhagic Fever, Ebola - pathology; Hemorrhagic Fever, Ebola - prevention & control; Hemorrhagic Fever, Ebola - virology; Humanities and Social Sciences; Humans; Immunoglobulin G - blood; Immunoglobulin M - blood; Immunotherapy; Kaplan-Meier Estimate; Lethal dose; Macaca mulatta; Monkeys; Monoclonal antibodies; multidisciplinary; Post-Exposure Prophylaxis; Primates; Science; Science (multidisciplinary); Stomatitis; Treatment Outcome; Vaccination; Vaccines; Vesicular stomatitis Indiana virus - immunology; Viral diseases; Viral Load - immunology